Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder and Different Psychiatric Comorbidities: An Eye-Tracking Study
The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
• Inclusion Criteria for Group 1:
⁃ i. Male or female, age 18 or older
⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to Diagnostic and Statistical Manual-5 (DSM-5) criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ iii. Currently in a depressive episode or currently in remission from a mood episode
⁃ iv. Young Mania Rating Scale total score ≤ 8
⁃ v. In the opinion of the investigator, capable of understanding and complying with protocol requirements
⁃ vi. In the opinion of the investigator, has the competency to understand and sign the informed consent
⁃ vii. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion
⁃ a. Inclusion Criteria for Group 2:
⁃ i. Male or female, age 18 or older
⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ iii. Currently in a depressive episode or currently in remission from a mood episode
⁃ iv. Meets diagnostic criteria for a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ v. Hamilton Anxiety Rating Scale total score ≥ 18
⁃ vi. Young Mania Rating Scale total score ≤ 8
⁃ vii. In the opinion of the investigator, capable of understanding and complying with protocol requirements
⁃ viii. In the opinion of the investigator, has the competency to understand and sign the informed consent
⁃ ix. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion
⁃ a. Inclusion Criteria for Group 3:
⁃ i. Male or female, age 18 or older
⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to the DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ iii. Meets diagnostic criteria for a substance use disorder within the last 3 months
⁃ iv. Meets diagnostic criteria for a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ v. Currently in a depressive episode or currently in remission from a mood episode
⁃ vi. Hamilton Anxiety Rating Scale total score ≥ 18
⁃ vii. Young Mania Rating Scale total score ≤ 8
⁃ viii. In the opinion of the investigator, capable of understanding and complying with protocol requirements
⁃ ix. In the opinion of the investigator, has the competency to understand and sign the informed consent
⁃ x. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion
⁃ a. Inclusion Criteria for Group 4:
⁃ i. Male or female, age 18 or older
⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to the DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)
⁃ iii. Meets diagnostic criteria for a substance use disorder within the last 3 months
⁃ iv. Currently in a depressive episode or currently in remission from a mood episode
⁃ v. Young Mania Rating Scale total score ≤ 8
⁃ vi. Hamilton Anxiety Rating Scale total score ≤ 12
⁃ vii. In the opinion of the investigator, capable of understanding and complying with protocol requirements
⁃ viii. In the opinion of the investigator, has the competency to understand and sign the informed consent
⁃ ix. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion
• Inclusion criteria for Group 5:
⁃ i. Male or female, age 18 or older
⁃ ii. In the opinion of the investigator, capable of understanding and complying with protocol requirements
⁃ iii. In the opinion of the investigator, has the competency to understand and sign the informed consent
⁃ iv. Physically healthy as determined by research psychiatrist
⁃ v. Without any current and/or lifetime psychiatric disorder as confirmed by the Mini International Neuropsychiatric Interview (MINI)